Published On: Wed, Oct 19th, 2016

Current Price Targets For Immune Pharmaceuticals Inc (IMNP)


Recently stock market analysts have updated their consensus ratings on shares of Immune Pharmaceuticals Inc (IMNP).

Most recent broker ratings

06/03/2016 – Immune Pharmaceuticals Inc had its “outperform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 3 price target on the stock.

10/13/2015 – Immune Pharmaceuticals Inc had its “buy” rating reiterated by analysts at Chardan Capital. They now have a USD 6.5 price target on the stock.

10/08/2015 – Roth Capital began new coverage on Immune Pharmaceuticals Inc giving the company a “buy” rating. They now have a USD 6 price target on the stock.

06/11/2015 – MLV & Co began new coverage on Immune Pharmaceuticals Inc giving the company a “buy” rating. They now have a USD 6 price target on the stock.

Immune Pharmaceuticals Inc has a 50 day moving average of 0.30 and a 200 day moving average of 0.37. The stock’s market capitalization is 18.99M, it has a 52-week low of 0.20 and a 52-week high of 1.54.

The share price of the company (IMNP) was down -1.24% during the last trading session, with a high of 0.25 and the volume of Immune Pharmaceuticals Inc shares traded was 1516268.